Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors (1995)

Peer-Reviewed Study · Didier AD, Loor F · 1995

Didier AD et al., 1995: Mouse study showing that strong P-glycoprotein blockers (SDZ PSC 833, SDZ 280-446) make normal mice hypersensitive to ivermectin, with signs consistent with central nervous system toxicity. It is the experimental basis for the warning that P-gp inhibitors can unmask ivermectin neurotoxicity.

When treated with such drugs, normal mice may display hypersensitivity to cyclosporin A and ivermectin.

Didier AD et al., 1995: Mouse study showing that strong P-glycoprotein blockers (SDZ PSC 833, SDZ 280-446) make normal mice hypersensitive to ivermectin, with signs consistent with central nervous system toxicity. It is the experimental basis for the warning that P-gp inhibitors can unmask ivermectin neurotoxicity. C4 drug-interaction mechanism. Study type: animal (mouse) experiment; N not stated in the abstract; France (Institut de Recherche Jouveinal / Universite Louis Pasteur affiliation implied, not stated in the abstract). Dose: ivermectin with the P-gp blockers SDZ PSC 833 or SDZ 280-446; route not stated in the abstract. Comparator: mice without P-gp blocker. Funder and declared conflicts: not in the PubMed record. Study type: animal.